Processes for preparing dihydropyrimidine derivatives and intermediates thereof
AssigneeSunshine Lake Pharma Co., Ltd.
InventorsQingyun REN, Xinchang LIU, Zhifu ZOU, Guanghua YAN, Mingchao BI, Siegfried GOLDMANN, Yingjun ZHANG
Life of this patent
Estimating the term…
Abstract
The present invention relates to processes for preparing a dihydropyrimidine derivative having Formula (I) or a tautomer thereof having Formula (Ia), as well as a intermediate thereof. The processes of the invention have simple operation, high optical purity of product, high yield and convenient work-up, which is suitable for industrial production.
Claims39
A process for preparing adihydropyrimidine compound having Formula (I), or a tautomer thereof having Formula (Ia),
- wherein each R is F;
- R2 is Cl or Br;
- R3 is C1-4 alkyl;
- Z is —O—, —S—, —S(═O)t—, or —N(R4)—;
- Y is —O—, —S—, —S(═O)t—, —(CH2)q—, or —N(R5)—;
- each t and q is independently 0, 1, or 2;
- each of R4 and R5 is independently H or C1-4 alkyl;
- each R6 is independently H, deuterium, halo, C1-4 alkyl, C1-4haloalkyl, amino, C1-4alkylamino, C1-4alkoxy, nitro, triazolyl, tetrazyl, —(CR7R7a)m—OH, —S(═O)qOR8a, —(CR7R7a)m—S(═O)qN(R8a)2, —(CR7R7a)t—N(R8a)2, —(CR7R7a)m—C(═O)O—R8, —(CR7R7a)m—C(═O)O—(CR7R7a)m—OC(═O)O—R8, —(CR7R7a)m—C(═O)O—(CR7R7a)m—OC(═O)—R8, —(CR7R7a)m—C(═O)O—(CR7R7a)m—C(═O)O—R8, —(CR7R7a)m—OC(═O)—R8, or —(CR7R7a)m—C(═O)—N(R8R8a);
- each R7a and R7 is independently H, halo, C1-4 alkyl, C1-4haloalkyl, —(CH2)m—OH, or —(CH2)m—C(═O)O—R8;
- or R7a and R7, together with the carbon atom to which they are attached, form a C3-6cycloalkyl group, C2-9 heterocyclylgroup, or —(C═O)—;
- each R8 and R8a is independently H, C1-4 alkyl, amino-C1-4-alkyl, C1-4alkoxy, C1-6 alkyl-S(═O)q—, C6-10 aryl, C1-9heteroaryl, C3-6cycloalkyl, C2-9heterocyclyl, C6-10 aryl-C1-6-alkyl, C1-9 heteroaryl-C1-6-alkyl, C3-6 cycloalkyl-C1-4-alkyl, C2-9 heterocyclyl-C1-6-alkyl, C2-9heterocyclyl-S(═O)q—, C1-9heteroaryl-S(═O)q—, C3-6cycloalkyl-S(═O)q—, C6-10 aryl-S(═O)q—, —(CH2)m—OH, —(CH2)m—C(═O)O—(CH2)m—H, or —(CH2)m—OC(═O)—(CH2)m—H;
- each R9 is independently H, halo, C1-4 alkyl, C1-4haloalkyl, C1-4 alkylthio, C3-6cycloalkyl, —(CR7R7a)m—C(═O)—N(R8R8a), or —(CR7R7a)m—C(═O)O—R8;
- R10 is H or deuterium;
- n is 0, 1, 2, 3, 4, or 5;
- each m is independently 0, 1, 2, 3, or 4;
- f is 1, 2, 3, or 4;
- and
- j is 0, 1, or 2;
- wherein the process comprises the steps of:
- step (A):
- reacting an amidine compound of Formula (II), or a salt thereof
- with an aldehyde compound of Formula (III)
- and a compound of Formula (IV)
- to obtain a compound of Formula (V),
- wherein R3b is C1-6alkoxy, C1-6alkylamino, C3-6cycloalkoxy, C3-6cycloalkylamino, C1-6 alkyl-C3-6-cycloalkoxy, C6-10arylamino, benzylamino, or benzyloxy;
- and
- R3a is H or C1-3 alkyl;
- step (B):
- halogenating the compound of Formula (V) to form a halide;
- and then reacting the halide with a compound of Formula (VI), or a salt thereof
- to obtain a compound of Formula (VII),
- step (C):
- forming the compound of Formula (I) or Formula (Ia) from the compound of Formula (VII) by means of a transesterification.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
16-23. (canceled)
(canceled)
(canceled)
(canceled)
A compound having Formula (V), or a tautomer thereof having Formula (V1), or a salt thereof, or a combination thereof,
- wherein each R1 is independently F;
- R2 is Cl or Br;
- R3b is C1-6alkoxy, C1-6alkylamino, C3-6cycloalkoxy, C3-6cycloalkylamino, C1-6 alkyl-C3-6-cycloalkoxy, C6-10arylamino, benzylamino, or benzyloxy;
- R3a is H or C1-3 alkyl;
- each R9 is independently H, halo, C1-4 alkyl, C1-4alkylthio, C1-4haloalkyl, C3-6cycloalkyl, —(CR7R7a)m—C(═O)—N(R8R8a), or —(CR7R7a)m—C(═O)O—R8;
- each R7a and R7 is independently H, halo, C1-4 alkyl, C1-4haloalkyl, —(CH2)m—OH, or —(CH2)m—C(═O)O—R8;
- or R7 and R7a, together with the carbon atom to which they are attached, form a C3-6cycloalkyl group, C2-9 heterocyclylgroup, or —(C═O)—;
- each R8 and R8a is independently H, C1-4 alkyl, amino-C1-4-alkyl, C1-4alkoxy, C1-6 alkyl-S(═O)q—, C6-10 aryl, C1-9heteroaryl, C3-6cycloalkyl, C2-9heterocyclyl, C6-10 aryl-C1-6-alkyl, C1-9 heteroaryl-C1-6-alkyl, C3-6 cycloalkyl-C1-4-alkyl, C2-9 heterocyclyl-C1-6-alkyl, C2-9heterocyclyl-S(═O)q—, C1-9heteroaryl-S(═O)q—, C3-6cycloalkyl-S(═O)q—, C6-10 aryl-S(═O)q—, —(CH2)m—OH, —(CH2)m—C(═O)O—(CH2)m—H, or —(CH2)m—OC(═O)—(CH2)m—H;
- each m is independently 0, 1, 2, 3, or 4;
- R10 is H or deuterium;
- f is 1, 2, 3, or 4;
- Z is —O—, —S—, —S(═O)t, or —N(R4)—;
- each of j and t is independently 0, 1, or 2;
- and
- R4 is H or C1-4 alkyl.
A process for preparing adihydropyrimidine compound having Formula (I), or a tautomer thereof having Formula (Ia),
- wherein each R1 is F;
- R2 is Cl or Br;
- R3 is C1-4 alkyl;
- Z is —O—, —S—, —S(═O)t—, or —N(R4)—;
- Y is —O—, —S—, —S(═O)t—, —(CH2)q—, or —N(R5)—;
- each t and q is independently 0, 1, or 2;
- each of R4 and R5 is independently H or C1-4 alkyl;
- each R6 is independently H, deuterium, halo, C1-4 alkyl, C1-4haloalkyl, amino, C1-4alkylamino, C1-4alkoxy, nitro, triazolyl, tetrazyl, —(CR7R7a)m—OH, —(CR7R7a)m—C(═O)O—R8, —(CR7R7a)t—N(R8a)2, —S(═O)qOR8a, —(CR7R7a)m—S(═O)qN(R8a)2, —(CR7R7a)m—C(═O)O—(CR7R7a)m—OC(═O)O—R8, —(CR7R7a)m—C(═O)O—(CR7R7a)m—OC(═O)—R8, —(CR7R7a)m—C(═O)O—(CR7R7a)m—C(═O)O—R8, —(CR7R7a)m—OC(═O)—R8, or —(CR7R7a)m—C(═O)—N(CR8R8a);
- each R7a and R7 is independently H, halo, C1-4 alkyl, C1-4haloalkyl, —(CH2)m—OH, or —(CH2)m—C(═O)O—R8, or R7a and R7, together with the carbon atom to which they are attached, form a C3-6cycloalkyl group, C2-9 heterocyclylgroup, or —(C═O)—;
- each R8 and R8a is independently H, C1-4 alkyl, amino-C1-4-alkyl, C1-4alkoxy, C1-6 alkyl-S(═O)q—, C6-10 aryl, C1-9heteroaryl, C3-6cycloalkyl, C2-9heterocyclyl, C6-10 aryl-C1-6-alkyl, C1-9 heteroaryl-C1-6-alkyl, C3-6 cycloalkyl-C1-4-alkyl, C2-9 heterocyclyl-C1-6-alkyl, C2-9heterocyclyl-S(═O)q—, C1-9heteroaryl-S(═O)q—, C3-6cycloalkyl-S(═O)q—, C6-10 aryl-S(═O)q—, —(CH2)m—OH, —(CH2)m—C(═O)O—(CH2)m—H, or —(CH2)m—OC(═O)—(CH2)m—H;
- each R9 is independently H, halo, C1-4 alkyl, C1-4 alkylthio, C1-4haloalkyl, C3-6cycloalkyl, —(CR7R7a)m—C(═O)—N(R8R8a), or —(CR7R7a)m—C(═O)O—R8;
- R10 is H or deuterium;
- n is 0, 1, 2, 3, 4, or 5;
- each m is independently 0, 1, 2, 3, or 4;
- f is 1, 2, 3, or 4;
- and
- j is 0, 1, or 2;
- wherein the process comprises the steps of:
- step (1):
- reacting an amidine compound of Formula (II), or a salt thereof
- with an aldehyde compound of Formula (III)
- and a compound of Formula (IV)
- to obtain a compound of Formula (V),
- step(2):
- forming a compound of Formula (X) from the compound of Formula (V) by means of a transesterification,
- wherein R3b is C1-6alkoxy, C1-6alkylamino, C3-6cycloalkoxy, C3-6-cycloalkylamino, C1-6 alkyl-C3-6-cycloalkoxy, C6-10arylamino, benzylamino, or benzyloxy;
- and
- R3a is H or C1-3 alkyl;
- and
- step (3):
- halogenating the compound of Formula (X) to form a halide;
- and then reacting the halide with a compound of Formula (VI), or a salt thereof to obtain a compound of Formula (I) or Formula (Ia),
40-60. (canceled)
62-63. (canceled)
(canceled)
Dependencies are inferred from the claim text.